Mr. Mitsakos is the Chairman and CEO of Arcadia Holdings, Inc., his wholly owned firm focused on private equity investments globally. Arcadia’s equity and debt partners include Canyon Partners, a $20 billion hedge fund, and Trust Company of the West, a $150 billion investment company. He is also a senior advisor to Sardis Capital, a London-based merchant bank; and Franklin Templeton China, in Shanghai, China.

In 1985, Mr. Mitsakos started his career as an investment banker at Goldman Sachs. From 1986 to 1989, he was a member of the corporate finance department at Drexel Burnham Lambert.

From 1989 to 1994, he was an affiliate of Acadia Partners, a private equity investment fund. With Acadia, he acquired six companies, and completed over ten follow-on acquisitions, totaling over $1 billion.

Mr. Mitsakos has been an advisor to Templeton International from 1995 to present. He has advised on investments in private and public companies based in emerging markets, including China. He now advises on public and private investment in China. These transactions total over $750 million, including a new public equity fund.

From 2003 to present, he has been an advisor to London-based Sardis Capital, a merchant bank he helped establish in 2003, focused on middle market acquisitions and M&A advise in Europe.

Also, from 1995 to present, he has been a private equity and venture capital investor, partnering with Canyon Partners, Trust Company of the West and SunAmerica, Inc. These investments ranged from technology-based startups to established manufacturing companies. Transactions have totaled almost $500 million. Current investment activity is focused on infrastructure, manufacturing, commodities and other well-established businesses.

Currently, he is Chairman of Cardax, and a member of the board of directors of Meru Networks.

He holds B.S. degrees in Computer Science and Microbiology from the University of Southern California (Valedictorian, 1981) and an MBA from Harvard University (1986). He taught at UCLA’s Anderson School of Business from 1992 to 1998, and is also on the board to UCLA’s Center for Cerebral Palsy within the UCLA Medical School.

Forward Looking Statements

This blog may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of said safe harbor provisions.
Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of our company, are generally identified by use of words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “seek,” “strive,” “try,” or future or conditional verbs such as “could,” “may,” “should,” “will,” “would,” or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Some of the factors that could cause our actual results to differ from our expectations or beliefs include, without limitation, the risks discussed from time to time in our filings with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this blog. Except as required by applicable law or regulation, we undertake no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.

This Blog is official and sanctioned by Cardax, Inc. | See Disclaimer and Terms of Use

Get Cardax, Inc. Blog Post Alerts